ADHD Patients Could Face Disrupted Access to Meds Following Fraud Case
FRIDAY, June 14, 2024 (HealthDay News) — The two top officers of a telehealth company that began to distribute ADHD drugs widely during the pandemic have been charged with health care fraud, the U.S. Department of Justice announced Thursday. The arrests will likely worsen ongoing shortages of Adderall and another ADHD medications, Vyvanse,Continue Reading